Allergy and Immunology | News, Education and Events

Recent News on Allergies and Immunologic Disorders

The following outside resources contain helpful information for families and healthcare professionals facing allergy- and immunology-related disorders. Cincinnati Children’s also provides further information on advocacy.

Info on COVID-19

Get updated information about the novel coronavirus (COVID-19) and how it affects patients with allergy / asthma conditions. Read more

In the News

December

What is the risk of allergic reaction to COVID-19 vaccines?
Amal H. Assa’ad, MD, comments about assessing allergic reactions to COVID-19 vaccines.  

U.S. Senate Passes FASTER Act, Brings Sesame Labeling One Step Closer for Food Allergy Community

November

Transferring Allergies in the Womb
Dr. Rothenberg shares his perspective on a recent article about how maternal mast cells are involved in allergy development in this invited Science Perspective.

Asian Children With Food Allergies More Likely to Experience Quality of Life Challenges

MSSRP Poster Award Winners
Susie Min and Rahul Sandella participated in the 10th Annual Research and Service Symposium at UC on Friday, November 6th. We appreciate UC providing a virtual forum for the MSSRP Program poster judging this year. Susie Min won second place for "Molecular Diagnosis of Eosinophilic Esophagitis from a Single Esophageal Biopsy" with the mentorship of Ting Wen, PhD and Marc Rothenberg, MD, PhD. She will represent us at the annual National Student Research Forum (NSRF) in Galveston, TX (April, 2021). Rahul Sandella won third place for "The Effects of Adiposity on Disease and Symptom Severity in Eosinophilic Esophagitis" with the mentorship of Vincent A. Mukkada, MD and Kara Kliewer, RD, PhD.

October

Anti–Siglec-8 Antibody for Eosinophilic Gastritis and Duodenitis
Patients with eosinophilic gastritis (EG) have limited therapeutic options. The Cincinnati Center for Eosinophilic Disorders is proud to have been an integral part of an important trial, now published in the New England Journal of Medicine, demonstrating that lirentelimab significantly and safely improves symptoms in subjects with EG while eradicating eosinophils. We are hopeful that the Phase 3 trial, which is now enrolling participants, will ultimately confirm these findings so that there are more clinically approved therapeutic options for individuals with this rare disorder.

Grateful Patient with Eosinophilia Thanks Cincinnati Children’s For Improved Life

September

Roots of New Drug for HES Trace Back to Cincinnati Children’s

Cincinnati Children's helps pave way for newly approved use of drug

Webinar: Peanut Oral Immunotherapy at Cincinnati Children's 

What is Eosinophilia?

Treatment for rare esophagus disease deemed breakthrough therapy by FDA: Dupixent shown to reduce esophageal inflammation

FDA Announces Guidance for Industry entitled “Eosinophilic Esophagitis: Developing Drugs for Treatment.”
This guidance is intended to describe the Agency's current thinking and recommended approach for the development of drugs and therapeutic biologics for the treatment of patients with eosinophilic esophagitis.

What it's like to get Palforzia, the first drug to treat peanut allergies in children

August 

How to Read a Food Label

July

Eosinophil responses during COVID-19 infections and coronavirus vaccinations

2020 Virtual Lab Day with the Rothenberg CURED Lab

Eosinophil responses during COVID-19 infections and coronavirus vaccinations 

May

FDA-Approved Drug Reverses Inflammation in Animal Model of Eosinophilic Esophagitis

Progress Update for Eosinophilic Disorder Research

EGIDExpress Tool Helps Accelerate EoE Research

EOS Network - Your Questions Answered by EOS Network Professionals

Unlocking the Secrets of Eosinophilic Esophagitis: A New Children’s Book

A preliminary report (not peer-reviewed) - Alpha I Antitrypsin is an Inhibitor of the SARS-CoV2-Priming Protease TMPRSS2

The ABCs of EGIDs - online web-based education module

SECURE-EoE/EGID - Coronavirus and EoE/EGID Reporting Database

Research survey for rare disease patients and their families about impacts of COVID-19

April

Congratulations to Melissa Mingler, MS, MBA, the Business Manager in the Division of Allergy and Immunology, on her election as Treasurer for the Midwest Section of the Society of Research Administrators International (SRAI). Mel currently serves as the Treasurer of the Ohio Chapter of SRAI and is now taking that experience to a higher level to serve the Midwest Section.

Congratulations to Rishi Mehta of the Rothenberg Lab for being selected as a 2020 Barry Goldwater Scholar by the Barry Goldwater Scholarship and Excellence in Education Foundation.

March

Kimberly A. Risma, MD, PhD was elected as Vice Chair of the Program Directors Assembly Executive Committee 2020-2022 and will serve as chair 2022-2024 for the American Academy of Allergy, Asthma and Immunology (AAAAI).

February 24

RDCRN Spotlight: Patients Power Research in Eosinophilic Gastrointestinal Disorders

February 21

Cincinnati Children's Patient Story: Nebraska Family Finds Answers and Food Options for Kids with EoE

February 19

EOS Network Website is Live!

February 17

Cincinnati Children's Patient Story: Three Matching Shirts, Three Matching Diagnoses

February 11

RDCRN Spotlight: NIH's Rare Diseases Clinical Research Network Launches New Logo

February 3

Michelle B. Lierl, MD celebrates with colleagues. 

Congratulations to our colleague Michelle B. Lierl, MD, who was recognized by the Patient and Family Experience (PFE) and Ambulatory teams this quarter for outstanding PFE in the Ambulatory setting. Dr. Lierl has been identified for this recognition based on a review of scores and positive comments that highlights the exceptional feedback she routinely receives from the patients and families she serves. During her February 3rd clinic, she was surprised with the news of this award!

February 3

Amal H. Assa’ad, MD speaks in this news video by WLWT5 about the FDA approving a new drug to help children with peanut allergy.

January

Research Horizons: New Tests May Help Diagnose Rare Subset of Eosinophilic Disorders

Our local colleague Michael G. Sherenian, MD, MS was selected as one of the 2020 AAAAI Foundation Faculty Development Award recipients, which is an honor and recognition of his accomplishments and plans.

Kimberly A. Risma, MD, PhD is making great strides in drug allergy treatment and awareness. Please support awareness of penicillin allergy and its over diagnosis by watching this video and learning more at the recently launched webpages of the Drug Allergy Program at Cincinnati Children's!

Marc E. Rothenberg, MD, PhD was pleased to assist NORD this year in preparation of the Eosinophilic Esophagitis report for the Rare Disease Database!

DECEMBER 4

How to Talk to Party Hosts About Kids' Nut Allergies

NOVEMBER 14

Lawmakers Propose Council to Help People With Rare Diseases

NOVEMBER 13

Nucala (mepolizumab) is the first treatment to show a significant reduction in flares for patients with Hypereosinophilic Syndrome (HES) 

NOVEMBER 7-10

5th CURED EGID Research Conference and Patient Education Program and "The CURED" Video

OCTOBER

Penicillin Allergy Testing Service set to launch in mid-November

OCTOBER 25

AP-1 activity induced by co-stimulation is rehired for chromatin opening during T cell activation

Marc E. Rothenberg, MD, PhD, shares, "I am pleased to share this research from the Barski Lab. This is an important contribution to the field, defining the epigenetic and transcriptional processes involved in T cell memory. This has direct implications in understanding the immunologic basis of a variety of diseases including allergy." 

OCTOBER 23 

5th CURED Research Conference and Patient Education Program Begins Nov. 7

OCTOBER 5

Efficacy of Dupilumab in Phase 2 Randomized Trial of Adults with Active Eosinophilic Esophagitis

Marc E. Rothenberg, MD, PhD, shares, "These positive data are good news for the patients, as this is a very promising therapy for eosinophilic esophagitis (EoE). This is also good news for the research field, as these clinical results are based on over a decade of research by the Rothenberg Lab, providing the scientific basis of blocking this pathway in EoE and related eosinophilic gastrointestinal disorders (EGIDs)." 

SEPTEMBER 21

Travel Award by Ohio Physiological Society

Rishi Mehta, a student in the Rothenberg Lab, was awarded the AD Instruments Travel Award of the Ohio Physiological Society, which will provide support for him to attend the Experimental Biology 2020 conference. He presented his research in the Rothenberg Lab under the title of "Loss of peptidyl-arginine deiminase 1-mediated citrullination drives esophageal epithelial barrier impairment in allergic inflammation".

OPS 2019 Award

AUGUST 5

Phase 2 Randomized, Double-Blind Placebo0Controlled Study in Patients with Eosinophilic Gastritis and/or Eosinophilic Gastroenteritis

Marc E. Rothenberg, MD, PhD, shares, "This is exciting news for the eosinophil gastrointestinal community. This early study met the key endpoints and looks promising for the future treatment of eosinophilic gastrointestinal disease. Here at Cincinnati Children's, we are pleased to have contributed to the preclinical research, design and implementation of this drug and study."

MARCH 12

Dr. Rothenberg received the Paul Ehrlich Lectureship Award

Dr. Rothenberg, the Principal Investigator for the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR), has been awarded the highest honor bestowed by the International Eosinophil Society for his major contributions to the advancement of our understanding of the eosinophil.

FEBRUARY 19 

Can an Antibody Against IL-13 Be Used to Treat Eosinophilic Esophagitis?

JANUARY 31 

FOX Cincinnati FARE Interview

Sandy Durrani, MD, discusses the increase of allergies on local Cincinnati FOX News in an interview arranged the by Food Allergy Research and Education (FARE).

JANUARY 16

Knopp Biosciences Expands Research Collaboration with Cincinnati Children's to Characterize Effect of Dexpramipexole in Inflammatory Diseases

Through a previous collaboration with Knopp, Patricia Fulkerson, MD, PhD and her team employed an induced pluripotent stem cell (iPSC) culture system to study the ability of dexpramipexole to inhibit the maturation of eosinophil progenitor cells. Looking forward, Dr. Fulkerson and her team will investigate molecular pathways in eosinophil development and attempt to further elucidate the effect of dexpramipexole on those pathways.

JANUARY

Allergy and Immunology Division: Select Research Advances of 2018 Video

Through our sustained commitment to research and clinical excellence for allergic and immunologic conditions, we will continue to change the outcome together. This slideshow highlights notable scientific advances made by The Division of Allergy and Immunology at Cincinnati Children’s in 2018. Our research has advanced the understanding, diagnosis, prevention, and treatment of many rare and common allergic and immunologic diseases.

JANUARY

Zuckerman Scholar

Netali Morgenstern-Ben Baruch is a 2018/2019 Zuckerman Israeli Postdoctoral Scholar of the Zuckerman Scholars Program and is investigating an inhibitory receptor, ILT-2, to learn about its role in the type 2 inflammatory disease Eosinophilic esophagitis (EoE).

NOVEMBER

Marc Rothenberg, MD, PhD Recognized as a Highly Cited Researcher for 2018

NOVEMBER 22

New Drug Could Be Game-changer For Kids With Severe Peanut Allergies

NOVEMBER 18

Landmark PALISADE Trial of AR101 Published in New England Journal of Medicine - read the open-access journal article

NOVEMBER 9

Anti-IL-13 Phase 2 Trial for Eosinophilic Esophagitis

OCTOBER

Proyecto EoE y Ausencia de Proteina SPINK7:Entrevista al Investigador Principal - see the October issue (pages 8-9) of the AEDESEO newsletter for an interview with Marc Rothenberg, MD, PhD

OCTOBER 24

Scientists Discover Why So Many Children Born With a Defective Esophagus Develop Severe Food Allergies

OCTOBER 22

DBV Technologies Announces Submission of Biologics License Application for Viaskin Peanut to the U.S. Food and Drug Administration

OCTOBER 18

A revolutionary treatment for allergies to peanuts and other foods is going mainstream--but do the benefits outweigh the risks?

OCTOBER 12

Thomas J. Fischer Endowed Education Fund

SEPTEMBER 7

Durrani Spem Facit

Our clinical team members are dedicated to excellence in patient care. For Sandy Durrani, MD, this was recently recognized by a grateful patient family naming a star “Durrani Spem Facit”, which loosely translates from Latin to mean ‘hope maker’. We are so proud of Sandy and all of our stellar team members for changing the outcome together.

JULY 3

Eosinophilic Esophagitis Video: What is EoE?

JUNE 6

Study Finds Absence of Key Protein, SPINK7, May Drive EoE: Replacement Therapy Reversed Effects in Tissue Experiments

MAY 2

Discovery Could Lead to Personalized Medical Therapies for Emerging New Food Allergy Disorder

JANUARY 3

Creating a multi-center rare disease consortium - the Consortium of Eosinophilic Gastrointestinal Disease Researchers
This is a fantastic summary of the formation of CEGIR, the Consortium of Eosinophilic Gastrointestinal Disease Researchers, the first large-scale collaboration between key stakeholders in the field of eosinophilic gastrointestinal disorders, including researchers, patients and the key funding agency, the NIH. CEGIR is dedicated to improving the lives of individuals with eosinophilic gastrointestinal disorders through innovative research, clinical expertise and education via collaborations between scientists, health care providers, patients, and professional organizations.

DECEMBER 5

Tips for Hosting a Food-Allergy-Friendly Holiday Party

NOVEMBER 16

Cincinnati Children's Research Paves Way For Newly Approved Asthma Drug

NOVEMBER 8

A Family Journey
The CURED Conference brought together patient families, physicians, and researchers from across the globe to learn from each other. One of the most moving and memorable presentations was a patient perspective from Kara Root, whose story inspires us here at Cincinnati Children’s as well those across the eosinophilic gastrointestinal disorder (EGID) community. You can read more about Kara and her family’s journey on her blog.

OCTOBER 23

Celebrating 140 Collective Years of Service of Allergy and Immunology at Cincinnati Children's
The Division of Allergy and Immunology is celebrating a unique year as six division faculty observe their 10-, 20-, 30-, and 40-year Cincinnati Children's service anniversaries! Their sustained contributions at multiple levels and their influence on past and future generations put the division in a strong position. Here, they offer insight into the changes they have been part of and where the division is going.

OCTOBER 10

Environmental Factors Could Adjust Risk of Eosinophilic Esophagitis in People with Particular Gene Variants

AUGUST 30

Handy Checklist: Going to College with an Eosinophilic Gastrointestinal Disorder

AUGUST 30

Pushing for Progress in a Rare Eosinophilic Condition: Eosinophilic Gastritis

JULY 17

What's the right time to use an EpiPen?
Amal H. Assa'ad, MD comments about administering epinephrine auto-injectors for anaphylaxis in this news video.

JULY 13

Family Fights For Formula Coverage Despite it Being Illinois Law
In this NCB Chicago news segment, Marc E. Rothenberg, MD, PhD and professional and family colleagues comment about insurance coverage for medical formulas.

MAY 22

FARE Patient Registry
The FARE Patient Registry launched on May 22, 2017 and is a patient-powered research registry, created with collaboration by FARE’s Medical Advisory Board, members of the Outcomes Research Advisory Board and AltaVoice, a leading registry platform and expert in the field of online protection and privacy.

MAY 17

FDA-approved drug helps treat rare immunologic disease, study finds
The NIH reports on a phase 3 clinical trail that they co-funded and that tested mepolizumab (humanized antibody against IL-5) as an alternative treatment for an eosinophilic syndrome, eosinophilic granulomatosis with polyangiitis (EGPA; previously known as Churg-Strauss syndrome).

MARCH 30

2017 FARE Research Retreat: Q&A with Dr. Simon Hogan
Simon P. Hogan, PhD, received a FARE Investigator in Food Allergy Award in 2015. With this support, the Hogan Lab is investigating how proteins released at the start of an allergic response can cause blood vessels to leak during life-threatening anaphylaxis. Understanding the chain of chemical events that leads to anaphylactic shock is a key step in devising strategies to prevent severe food allergy symptoms. Hogan presented at the FARE 2017 Research Retreat and explains his work in this Q&A on the FARE blog.

MARCH 28

Poster of Distinction, Nutrition Research Day
Mark Rochman, PhD, and Carina Venter, PhD, RN, and their students, Rachel Ernst and Tarah Wagner won the Poster of Distinction at the Nutrition Research Day Poster Session at Cincinnati Children's for their work on peanut protein levels.Ernst and Wagner went on to take first place in the Agriculture / Food Science category at their high school's capstone competition on April 28.

Poster of Distinction at Nutrition Research Day 2017.

MARCH 16

K08 Award
Andrew W. Lindsley, MD, PhD was awarded a K08 from the National Institute of Allergy and Infectious Diseases (NIAID). This NIH clinical scientist career development award will support the Lindsley Lab in investigating how the sphingolipid ORMDL3 regulates dendritic cells in asthma.

MARCH 15

NIH R01 and DHC Awards
Patricia C. Fulkerson, MD, PhD was awarded an R01 from National Institute of Allergy and Infectious Diseases (NIAID). This R01 will support the Fulkerson Lab in investigating the role of the transcription factor Aiolos in eosinophilic asthma. Learn more about her research in the Fulkerson Lab.

MARCH 3-6

2017 AAAAI Annual Meeting Awards
For the 2017 American Academy of Asthma, Allergy & Immunology (AAAAI) Annual Meeting, our Cincinnati Children’s/University of Cincinnati College of Medicine colleagues presented over 50 presentations, which is an impressive number. This underscores the collective impact that Cincinnati Children’s/University of Cincinnati College of Medicine is having in our field. Dr. Justin Wheeler was the recipient for the award for the 2017 AAAAI/APFED Best Oral Abstract on eosinophilic gastrointestinal diseases by a fellow-in-training. Amnah Yamani, a predoctoral student in the Hogan Lab, was selected to be in the featured poster session. Amal H. Assa’ad, MD, was selected to give the first Leonard Bernstein Lectureship. This lectureship was established in memory of our legendary Dr. Leonard Bernstein, who was a pioneer in the allergy field, founder of the allergy discipline in Cincinnati and a wonderful mentor and contributor to our program. The lectureship was sponsored by donations from the Bernstein Family and Dr. Bernstein’s past trainees and colleagues.

MARCH 5

FADDA Interest Section
Amal H. Assa’ad, MD, was elected by her peers to serve as the Secretary of the AAAAI’s Food allergy, anaphylaxis, dermatology and drug Allergy (FADDA) Interest Section from March 5, 2017 until March 2019. After the 2019 AAAAI Annual Meeting and until the 2021 Annual Meeting, she will serve in the role as the Vice Chair of the interest section, and then from 2021 until 2023, she will serve in the role of Chair of FADDA.

FEBRUARY 17

Clinical Care Award
Michelle B. Lierl, MD, was selected by The Faculty Awards Committee at Cincinnati Children's for the Clinical Care Award. This is a well-deserved honor for Dr. Lierl, who is now in her 30th anniversary year at Cincinnati Children's. In addition to her great clinical service, Dr. Lierl researches fungal allergens in the Lierl Lab and has created a fungal spore photo website.

JANUARY 17

2016 Division Research Advances Video
We invite you to watch a short video detailing a few of the Division of Allergy and Immunology’s Research Advances of 2016. Through our sustained commitment to research and clinical excellence for allergic and immunologic conditions, we will continue to change the outcome together.

JANUARY 3

CURED Foundation donates for Eosinophilic Disorder Treatment and Research
The Campaign Urging Research for Eosinophilic Disease (CURED), a not-for-profit foundation dedicated to those suffering from eosinophilic disorders, has donated $200,000 to the Cincinnati Center for Eosinophilic Disorders (CCED), based at Cincinnati Children’s Hospital Medical Center. The CURED Foundation works extensively in supporting families and raising funds for research. One-hundred percent of funds raised by the CURED Foundation go to research for eosinophilic disorders. To date, CURED has contributed over 4 million dollars to research.

JANUARY

2017 NIAID Addendum Guidelines for Preventing Peanut Allergy
In 2015, findings from a landmark NIAID-funded clinical trial called the Learning Early About Peanut (LEAP) study showed that introducing peanut-containing foods to infants at high risk for developing peanut allergy was safe and led to an 81% relative reduction in the subsequent development of peanut allergy. Due to the strength of these results, NIAID established a coordinating committee that convened an expert panel to update the 2010 Guidelines to specifically address the prevention of peanut allergy. Amal H. Assa'ad, MD, and Carina Venter, PhD, RD, contributed to the Addendum Guidelines for the Prevention of Peanut Allergy in the United States that were published in the January 2017 issue of Annals of Allergy and Immunology, along with a guest editorial by Amal H. Assa'ad, MD.

JANUARY

2017 AAAAI Distinguished Service Award
Well-deserved congratulations go to Kimberly A. Risma, MD, PhD, for being selected for the 2017 Distinguished Service Award of the American Academy of Asthma, Allergy & Immunology (AAAAI) for her leadership with the Chrysalis Project. The Chrysalis Project is a program for medical students and internal medicine and/or pediatric residents that provides them the opportunity to explore a career in allergy/immunology. It is housed within the AAAAI Annual Meeting and includes pairing the Chrysalis mentee with a fellow-in-training mentor, didactic lectures with allergy/immunology faculty, career option presentations, and free conference registration and access to the leading knowledge in the hundreds of AAAAI meeting sessions, workshops, symposia, seminars, and oral abstracts. Dr. Risma has helped to propel this program to become a jewel of our society and is thus greatly impacting our field and its future. Through her efforts, she has established a ‘pipeline’ of strong physicians in our field. In 2010, Dr. Risma was nominated by the Board of AAAAI to assume the co-Chair position of the Chrysalis Program Project after a pause in the program’s funding. She has subsequently worked tirelessly on the Chrysalis Project with current AAAAI president, Dr. Tom Fleisher between 2010-15 and former AAAAI president, Dr. Wesley Burks in 2015-17. Under her leadership, the program has expanded from 20 to 50 attendees per year. The Chrysalis Project has been extraordinarily well received as is evident from the growing number of highly qualified applicants and attendees, the positive reviews, and the growing number of fellowship applicants who credit the Chrysalis Project.

Understanding Food Allergy

The National Institute of Allergy and Infectious Diseases explains food allergy and offers tips on how to manage the condition.

Ghory Lecture

The Ghory Lecture is an annual event presented by the Division of Allergy and Immunology at Cincinnati Children’s and the Cincinnati Asthma and Allergy Society. It began in 1991 and was named in honor of Joseph E. Ghory, MD.

Joseph E. Ghory, M.D.

1915-1988

Joseph E. Ghory, M.D. treats a patient. Dr. Joseph Ghory was born and raised in Cincinnati, Ohio. He received his M.D. from the Ohio State University College of Medicine in 1939. After completing a pediatric residency at the Children's Hospital in Cincinnati, he practiced general pediatrics in Cincinnati for 17 years.

He was devoted to teaching and was instrumental in establishing the pediatric residency training program at Good Samaritan Hospital, where he served as the first director of pediatric education. He was elected president of the Cincinnati Pediatric Society, the Children’s Hospital Medical Staff and the Academy of Medicine of Cincinnati. Impressed by the large number of children with allergic diseases, he sought additional training in allergy and became the first board-certified pediatric allergist in Cincinnati in 1960. Together with Dr. Leonard Bernstein, Dr. Ghory established the Allergy Fellowship at the University of Cincinnati and the Children’s Hospital.

Dr. Ghory’s special interest and vision was the long-term care and rehabilitation of children with intractable asthma, using a community approach with involvement of the family and a limited hospital stay. He thus became director of the Convalescent Hospital for Children in Cincinnati, organized and presided over the national Association of Convalescent Homes and Hospitals for Asthmatic Children and was chairman of the Rehabilitation Committee of the American Academy of Allergy and Immunology.

Dr. Ghory’s greatest pride was his family, and his legacy lives on in two of his daughters, Ann Ghory, M.D. and Patricia Ghory, M.D., who are practicing allergists in the Cincinnati area, and now in three of his grandchildren, who are now our young practicing and future allergists. 

2020-

2020 – Sandy Durrani and Justin Schwartz

2010-2019

2019 – William W. Busse

2018 – Seema Aceves

2017 – Elizabeth Phillips

2016 – Carina Venter

2015 – Kara Shah

2014 – Linda Cox

2013 – Kimberly Risma

2012 – David Fleischer

2011 – Amal Assa’ad

2000-2009

2009 – Marc Rothenberg

2008 – Scott Sicherer

2007 – Carolyn Kercsmar

2006 – Jim Gern

2005 – Sally Wenzel

2004 – Anne-Marie Irani

2003 – Donald Leung

2002 – Fernando Martinez

2001 – Marianne Frieri

2000 – Wesley Burks

1991-1999

1999 – Alan Kaplan

1998 – Bruce Bochner

1997 – Robert Lemanske

1996 – Peter Creticos

1995 – Michael Blais

1994 – Paul Greenberger

1993 – Elliot Ellis

1992 – Louise Marker

1991 – Sami Bahna

Allergy / Immunology Fellowship

Our recent group of fellows.
Our division offers fellowship training in pediatric and adult Allergy / Immunology in collaboration with the University of Cincinnati. Read more

Faculty Awards | Michelle Lierl, MD

Michelle B. Lierl, MD, has been recognized for her excellence in clinical care with a Clinical Care Achievement Award.

Michelle B. Lierl, MD, has been recognized for her excellence in clinical care with a Clinical Care Achievement Award.

Read More
Read the blog.
Learn more about allergy and immunology on the Cincinnati Children’s blog. Read Our Blog

Research Science Blog

Learn more about research efforts on eosinophilic conditions. The Research Horizons blog provides news and insights about the latest discoveries and innovations developed by the scientists of Cincinnati Children’s.

Read More

Research Highlights

Our research spans fundamental studies, translational investigation, and clinical trials. Novel models of immunologic diseases, developed and / or fine-tuned by divisional researchers, provide unprecedented systems to investigate key inflammatory steps involved in pediatric allergic and immunologic disease and to enhance our understanding of mast cells, eosinophils, macrophages and lymphocytes. Read More